dc.contributor.author | Akbarialiabad, Hossein | |
dc.contributor.author | Taghrir, Mohammad H | |
dc.contributor.author | Abdollahi, Ashkan | |
dc.contributor.author | Ghahramani, Nasrollah | |
dc.contributor.author | Kumar, Manasi | |
dc.contributor.author | Paydar, Shahram | |
dc.contributor.author | Razani, Babak | |
dc.contributor.author | Mwangi, John | |
dc.contributor.author | Asadi-Pooya, Ali A | |
dc.contributor.author | Malekmakan, Leila | |
dc.contributor.author | Bahar, Bastani | |
dc.date.accessioned | 2021-08-13T07:21:35Z | |
dc.date.available | 2021-08-13T07:21:35Z | |
dc.date.issued | 2021-07 | |
dc.identifier.citation | Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, Razani B, Mwangi J, Asadi-Pooya AA, Malekmakan L, Bastani B. Long COVID, a comprehensive systematic scoping review. Infection. 2021 Jul 28:1–24. doi: 10.1007/s15010-021-01666-x. Epub ahead of print. PMID: 34319569; PMCID: PMC8317481. | en_US |
dc.identifier.uri | https://pubmed.ncbi.nlm.nih.gov/34319569/ | |
dc.identifier.uri | http://erepository.uonbi.ac.ke/handle/11295/155179 | |
dc.description.abstract | Purpose: To find out what is known from literature about Long COVID until January 30, 2021.
Methods: We undertook a four-step search with no language restriction. A preliminary search was made to identify the keywords. A search strategy of all electronic databases resulted in 66 eligible studies. A forward and backward search of the references and citations resulted in additional 54 publications. Non-English language articles were translated using Google Translate. We conducted our scoping review based on the PRISMA-ScR Checklist.
Results: Of 120 papers, we found only one randomized clinical trial. Of the 67 original studies, 22 were cohort, and 28 were cross-sectional studies. Of the total 120 publications, 49.1% focused on signs and symptoms, 23.3% on management, and 10.8% on pathophysiology. Ten publications focused on imaging studies. The results are also presented extensively in a narrative synthesis in separated sections (nomenclature, diagnosis, pathophysiology, risk factors, signs/symptoms, management).
Conclusions: The controversies in its definition have impaired proper recognition and management. The predominant symptoms were: fatigue, breathlessness, arthralgia, sleep difficulties, and chest pain. Recent reports also point to the risk of long-term sequela with cutaneous, respiratory, cardiovascular, musculoskeletal, mental health, neurologic, and renal involvement in those who survive the acute phase of the illness. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | COVID-19; Corona virus; Long COVID-19; Long haulers COVID; Novel Corona Virus 2019; | en_US |
dc.title | Long COVID, a comprehensive systematic scoping review | en_US |
dc.type | Article | en_US |